BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2026.
World J Gastroenterol. Feb 14, 2026; 32(6): 115556
Published online Feb 14, 2026. doi: 10.3748/wjg.v32.i6.115556
Table 3 Adverse treatment reaction, n (%)
Before PSM
After PSM
HIPEC + AC group
AC group
χ2
P value
HIPEC + AC group
AC group
χ2
P value
Myelosuppression0.9120.3391.0060.316
Yes27 (28.13)44 (34.11)24 (30.00)30 (37.50)
No69 (71.88)85 (65.89)56 (70.00)50 (62.50)
Liver function abnormalities0.0470.8290.0001.000
Yes11 (11.46)16 (12.40)10 (12.50)10 (12.50)
No85 (88.54)113 (87.60)70 (87.50)70 (87.50)


Write to the Help Desk